A class action lawsuit was filed against Semler Scientific SMLR +1.02% on August 29, 2025. The plaintiffs (shareholders) alleged that they bought SMLR stock at artificially inflated prices between March 10, 2021, and April 15, 2025 (Class Period) and are now seeking compensation for their financial losses. Investors who bought SMLR stock during that period can click here to learn about joining the lawsuit.
Semler Scientific is a MedTech company focused on developing novel solutions to give providers and their patients the opportunity to detect early signs of chronic diseases. Its flagship product, QuantaFlo, is approved by the U.S. FDA for the measurement of arterial blood flow in the extremities.
The company’s failure to disclose a material investigation by the U.S. Department of Justice (DOJ) into violations of the False Claims Act is at the heart of the current complaint. The False Claims Act protects federal programs, such as Medicare and defense contracts, from fraud and misuse, while encouraging whistleblowers to report fraud through financial rewards and legal protections.
According to the lawsuit, SMLR and three of its current and/or former senior officers (the Defendants) repeatedly made false and misleading public statements...
Yep. I have, unfortunately, seen a number of cases during my career that involved false allegations of sexual harassment made against an employee, usually a member of management. And usually male....